{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-10-15T12:24:39.355058+00:00",
  "news": [
    {
      "title": "Amgen prevails as Madras High Court reinforces balanced framework for assessing patent eligibility - IAM Media",
      "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOdVJwWk1HMDhRVi1tdFJ4LVZsQWN2SF82eU53TnZtckd3dnM4R0VxWC1zcG1zU0pKMnBTdnVock92N3JEZ0wtMW5PUGVfVWxManFKODVTOTFjRjF1azhRQUtJcnBsQ0VGYUFkLXlCX0UtRDVsQ1Z3RHpDWkhNOURQakVvWlBiR0hSOWhzZG90eHpuVkJHXzRHZlJGTUdxQ2NmLUFFeWo3Zk0yLUItcHd3MGhDYTlyaFAzazV5b1NCYnlUOFk?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOdVJwWk1HMDhRVi1tdFJ4LVZsQWN2SF82eU53TnZtckd3dnM4R0VxWC1zcG1zU0pKMnBTdnVock92N3JEZ0wtMW5PUGVfVWxManFKODVTOTFjRjF1azhRQUtJcnBsQ0VGYUFkLXlCX0UtRDVsQ1Z3RHpDWkhNOURQakVvWlBiR0hSOWhzZG90eHpuVkJHXzRHZlJGTUdxQ2NmLUFFeWo3Zk0yLUItcHd3MGhDYTlyaFAzazV5b1NCYnlUOFk?oc=5\" target=\"_blank\">Amgen prevails as Madras High Court reinforces balanced framework for assessing patent eligibility</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">IAM Media</font>",
      "published": "2025-10-15T09:41:02+00:00",
      "source": "IAM Media"
    },
    {
      "title": "Amgen (AMGN) Announces Launch of AmgenNow - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMiigFBVV95cUxOR09SMHp3TFNzM1l5V2Z6VEJBYV9KSVFTdDFHbDQ3RVIyZ3RvVHJ0N2xKdzNUcmdTRVFmZ09PNmkwbEI5SFlQUDI4ZjVsXzFPOWlwZVM5Yk9HU3ZOWDdZZlJoMFVpRjVPaDVlWGJWbGJSWWpmdGptajlyMW9oQTFzSEJ5VG02Rk5rVFE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiigFBVV95cUxOR09SMHp3TFNzM1l5V2Z6VEJBYV9KSVFTdDFHbDQ3RVIyZ3RvVHJ0N2xKdzNUcmdTRVFmZ09PNmkwbEI5SFlQUDI4ZjVsXzFPOWlwZVM5Yk9HU3ZOWDdZZlJoMFVpRjVPaDVlWGJWbGJSWWpmdGptajlyMW9oQTFzSEJ5VG02Rk5rVFE?oc=5\" target=\"_blank\">Amgen (AMGN) Announces Launch of AmgenNow</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-14T17:06:15+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Lobbying Update: $15,000 of AMGEN INC. lobbying was just disclosed - Quiver Quantitative",
      "link": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPMkhRTW5ydl9RbUZrZkZBaHFFQXZWVjZhNWlUVlEzb0RFVnNHdWs4ZEo1dGIyZ20zbkViekx4RC1qR3I4SVhRY3JPbldKczZ2bnFUYWlBS2Q1b2laMkt0NkUxV3JPZ2hwdEE2c2pCS09vTXJYb2NlY0JaSjZkR0lXa294ZHpGRV9ybUZKQVl3S09iMkdhWjZjdnBxMVZ6di0yVlFxWld3OEQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPMkhRTW5ydl9RbUZrZkZBaHFFQXZWVjZhNWlUVlEzb0RFVnNHdWs4ZEo1dGIyZ20zbkViekx4RC1qR3I4SVhRY3JPbldKczZ2bnFUYWlBS2Q1b2laMkt0NkUxV3JPZ2hwdEE2c2pCS09vTXJYb2NlY0JaSjZkR0lXa294ZHpGRV9ybUZKQVl3S09iMkdhWjZjdnBxMVZ6di0yVlFxWld3OEQ?oc=5\" target=\"_blank\">Lobbying Update: $15,000 of AMGEN INC. lobbying was just disclosed</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Quiver Quantitative</font>",
      "published": "2025-10-14T23:07:00+00:00",
      "source": "Quiver Quantitative"
    },
    {
      "title": "Aanika’s Journey: Life After a Severe Asthma Diagnosis - Amgen",
      "link": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPdEsyLXV4V3pjZmVFc2JOT21vZFJzakpCSEQ1ZlVlMXNqMms3UGRQV05UeEhaQm5nbXRLZl9aM1JFX2pjbWNtb3NwUnowMmI5OF9JT00yOFY1dXlhYXNFc0k0eF9Td0hWMmRLR0UzenBEY2EtbXpBSk96cVpVT2Q0YWUwSm9uLWJBc2J1ZXNlMEZWMS12Yk0w?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilwFBVV95cUxPdEsyLXV4V3pjZmVFc2JOT21vZFJzakpCSEQ1ZlVlMXNqMms3UGRQV05UeEhaQm5nbXRLZl9aM1JFX2pjbWNtb3NwUnowMmI5OF9JT00yOFY1dXlhYXNFc0k0eF9Td0hWMmRLR0UzenBEY2EtbXpBSk96cVpVT2Q0YWUwSm9uLWJBc2J1ZXNlMEZWMS12Yk0w?oc=5\" target=\"_blank\">Aanika’s Journey: Life After a Severe Asthma Diagnosis</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2025-10-13T16:53:45+00:00",
      "source": "Amgen"
    },
    {
      "title": "Amgen Direct-to-Patient Program Aims to Expand Access to Evolocumab Amid US Drug Pricing Reforms - AJMC",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNOWJqUGtjRG9IVGhVOVE1SFgtS0hYQlRab1pxTHJWbTNScFlRQkRoRUNqdF96bEs1RmZURFlNVWg2MElWS2JGUHlzd2N6NFozeE8yQlZFVElhZ21UOEJKdW9EazRnanBud3JqUlAzV3A0RVM1TjlNNVQ4X1lFMnBTRnpCQlBpRTBMMElySk1mUXlRd2RrN3NCYV9zazV4c2pYUW94N0VpSE1tcTByc01SVmNYUDNBLVY0YV9yb3ZFYw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNOWJqUGtjRG9IVGhVOVE1SFgtS0hYQlRab1pxTHJWbTNScFlRQkRoRUNqdF96bEs1RmZURFlNVWg2MElWS2JGUHlzd2N6NFozeE8yQlZFVElhZ21UOEJKdW9EazRnanBud3JqUlAzV3A0RVM1TjlNNVQ4X1lFMnBTRnpCQlBpRTBMMElySk1mUXlRd2RrN3NCYV9zazV4c2pYUW94N0VpSE1tcTByc01SVmNYUDNBLVY0YV9yb3ZFYw?oc=5\" target=\"_blank\">Amgen Direct-to-Patient Program Aims to Expand Access to Evolocumab Amid US Drug Pricing Reforms</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AJMC</font>",
      "published": "2025-10-06T07:00:00+00:00",
      "source": "AJMC"
    },
    {
      "title": "AMGEN ANNOUNCES $650M EXPANSION OF U.S. MANUFACTURING, CREATING HUNDREDS OF NEW JOBS - PR Newswire",
      "link": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxOVC03UXRKQ3Q4OTFzYjh5bUV6WWRRRHVOU2pqcDY1MGhUbm1PQnZCTEpQYzZhcFlsN2pDSHZTU0xib0JuVVhuTlBMMVVuRGhtX1F0clBxVHM2Z2lUR1VRSkItM3VvVGh6R0NPMWhaTkRZRGVOVlFhNzdGUkZ5UWpzRk4zU2xIdkdRMkFrRl83UjB2LXFjMWdRUXh1aUs3WG94SXI5NWJqVVEyYzFSZVY5TERfZGlJOC1DbVM4RnNBbFJOVW9GbW9PQ1NydXBsdHdtTkE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi0gFBVV95cUxOVC03UXRKQ3Q4OTFzYjh5bUV6WWRRRHVOU2pqcDY1MGhUbm1PQnZCTEpQYzZhcFlsN2pDSHZTU0xib0JuVVhuTlBMMVVuRGhtX1F0clBxVHM2Z2lUR1VRSkItM3VvVGh6R0NPMWhaTkRZRGVOVlFhNzdGUkZ5UWpzRk4zU2xIdkdRMkFrRl83UjB2LXFjMWdRUXh1aUs3WG94SXI5NWJqVVEyYzFSZVY5TERfZGlJOC1DbVM4RnNBbFJOVW9GbW9PQ1NydXBsdHdtTkE?oc=5\" target=\"_blank\">AMGEN ANNOUNCES $650M EXPANSION OF U.S. MANUFACTURING, CREATING HUNDREDS OF NEW JOBS</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
      "published": "2025-09-26T07:00:00+00:00",
      "source": "PR Newswire"
    },
    {
      "title": "Global biotech leaders Amgen and Gilead announcing expansions in California, the #1 state for life sciences - California State Portal (.gov)",
      "link": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxQNkFQNVUxYWlJQU1YZlpBSXFrUEotWnBHU1hEQ0lmcU0wR25nX3hETGkxV2M2UVN5NW5ZNHdjYS03NVAyUTBWVjJIZkRyUmR3cXBfUVFjUHVDWDFhYlZSTEhqTlFyenIyNXphZXcyVzNLMml4dlhxeG1qa1dWck1uY1J0SmdaeW9NQ3JmOHNZcnpBR1V2cVAyaXZIXzcxYkFWR3FyTi01NWtFaGE4WGZtbFRlOEQ2ajFJdGpRQ2FDbnBXd3RwbVZob2lJQzZVQWVXOU9VWkxscw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1wFBVV95cUxQNkFQNVUxYWlJQU1YZlpBSXFrUEotWnBHU1hEQ0lmcU0wR25nX3hETGkxV2M2UVN5NW5ZNHdjYS03NVAyUTBWVjJIZkRyUmR3cXBfUVFjUHVDWDFhYlZSTEhqTlFyenIyNXphZXcyVzNLMml4dlhxeG1qa1dWck1uY1J0SmdaeW9NQ3JmOHNZcnpBR1V2cVAyaXZIXzcxYkFWR3FyTi01NWtFaGE4WGZtbFRlOEQ2ajFJdGpRQ2FDbnBXd3RwbVZob2lJQzZVQWVXOU9VWkxscw?oc=5\" target=\"_blank\">Global biotech leaders Amgen and Gilead announcing expansions in California, the #1 state for life sciences</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">California State Portal (.gov)</font>",
      "published": "2025-09-15T07:00:00+00:00",
      "source": "California State Portal (.gov)"
    },
    {
      "title": "Amgen to sell cholesterol drug at 60% discount to cash-paying US patients - Reuters",
      "link": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQY093WGV4Y3o1SmQ5TElWbXNtbUxhYUgyLTNNXzdnTUM4dEphOVZ1ZkNieUNlbGx0SmtNbzRpaWVRY1VnVFpld2RVMU5Xc0E1WjJ6RlVCeDkwQ25kOVlMekI5MGlNaW5UZUN0dVdKWWFfQ0ExMjJIUEIwakxQckd1eFc4YzROWUxwZ1h6T0RsdXFGTXNIQTdXSk1FWUwxOVZkTkdmdW53TlRZdGZMRDE1eHB1MVNoZzMzUExrQ1UxRTJGRGw1dF84V200VQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiywFBVV95cUxQY093WGV4Y3o1SmQ5TElWbXNtbUxhYUgyLTNNXzdnTUM4dEphOVZ1ZkNieUNlbGx0SmtNbzRpaWVRY1VnVFpld2RVMU5Xc0E1WjJ6RlVCeDkwQ25kOVlMekI5MGlNaW5UZUN0dVdKWWFfQ0ExMjJIUEIwakxQckd1eFc4YzROWUxwZ1h6T0RsdXFGTXNIQTdXSk1FWUwxOVZkTkdmdW53TlRZdGZMRDE1eHB1MVNoZzMzUExrQ1UxRTJGRGw1dF84V200VQ?oc=5\" target=\"_blank\">Amgen to sell cholesterol drug at 60% discount to cash-paying US patients</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-10-06T07:00:00+00:00",
      "source": "Reuters"
    }
  ],
  "product_launches": [
    {
      "title": "Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5\" target=\"_blank\">Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-09-10T07:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "Strong first-quarter product sales for Amgen - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5\" target=\"_blank\">Strong first-quarter product sales for Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2025-05-02T07:00:00+00:00",
      "source": "The Pharma Letter"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Amgen Confirms Launch Of First US Eculizumab Rival - insights.citeline.com",
      "link": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxQVHFOTU9KXzdESTJJc2dLZFF0Q1RMYTFoT3JHeElVd1pxUEdqbDRzdTZkZmQ3eWJZYmpGb1BLMTB6UVctcHVMLWUwNkluT280b215TDNBaFFranlMbll1S2w3QnlJWjFPNDVQZ3ZObmtfZlUxcXZJWEdIaU45Ym1heWJfWUpQTEtZRDNEY281UmprYkZab2RhS05HaUhRTjltZXZ6RG1SRnNlZzRHb05Yc2IwSWRlZHNKZzM1NWF5dzBxbTV2Zlo0blFBU291SkRSUU9QSl91dVJzRVFWakRHNA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi4AFBVV95cUxQVHFOTU9KXzdESTJJc2dLZFF0Q1RMYTFoT3JHeElVd1pxUEdqbDRzdTZkZmQ3eWJZYmpGb1BLMTB6UVctcHVMLWUwNkluT280b215TDNBaFFranlMbll1S2w3QnlJWjFPNDVQZ3ZObmtfZlUxcXZJWEdIaU45Ym1heWJfWUpQTEtZRDNEY281UmprYkZab2RhS05HaUhRTjltZXZ6RG1SRnNlZzRHb05Yc2IwSWRlZHNKZzM1NWF5dzBxbTV2Zlo0blFBU291SkRSUU9QSl91dVJzRVFWakRHNA?oc=5\" target=\"_blank\">Amgen Confirms Launch Of First US Eculizumab Rival</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">insights.citeline.com</font>",
      "published": "2025-03-05T08:00:00+00:00",
      "source": "insights.citeline.com"
    },
    {
      "title": "Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxONkt3YUVEeUpwTU5LYVgtaTk2THhoMEt3ZUliWC1sWmhTTGR4M0hwaVpFMEFla01mUTdxbGVueWNGVThVT3U1T3R2NTQwaEkxeEI5MjRPMzVQUlhaU3hKNVVqQmFFY3BMQ2c3enphdTVLVy1Wb3dTb0l4Rnk3czFVTVFZbUdvVVJwa1I4Z3FDOFByVDZIV21Ccnk5VTd5U3VtNHhuVDdQUldHNm81YnZ6MHFReDBJNmk1S3BucTJhUlplcnc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwwFBVV95cUxONkt3YUVEeUpwTU5LYVgtaTk2THhoMEt3ZUliWC1sWmhTTGR4M0hwaVpFMEFla01mUTdxbGVueWNGVThVT3U1T3R2NTQwaEkxeEI5MjRPMzVQUlhaU3hKNVVqQmFFY3BMQ2c3enphdTVLVy1Wb3dTb0l4Rnk3czFVTVFZbUdvVVJwa1I4Z3FDOFByVDZIV21Ccnk5VTd5U3VtNHhuVDdQUldHNm81YnZ6MHFReDBJNmk1S3BucTJhUlplcnc?oc=5\" target=\"_blank\">Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-01-28T08:00:00+00:00",
      "source": "Fierce Pharma"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-10-14",
      "close": 293.8500061035156
    },
    "history": [
      {
        "date": "2025-10-06",
        "close": 294.1199951171875
      },
      {
        "date": "2025-10-07",
        "close": 295.5400085449219
      },
      {
        "date": "2025-10-08",
        "close": 294.6199951171875
      },
      {
        "date": "2025-10-09",
        "close": 295.42999267578125
      },
      {
        "date": "2025-10-10",
        "close": 290.1300048828125
      },
      {
        "date": "2025-10-13",
        "close": 292.3999938964844
      },
      {
        "date": "2025-10-14",
        "close": 293.8500061035156
      }
    ],
    "name": "Amgen Inc."
  }
}